ROJUZDA Trademark

Trademark Overview

On Monday, July 13, 2015, a trademark application was filed for ROJUZDA with the United States Patent and Trademark Office. The USPTO has given the ROJUZDA trademark a serial number of 86690898. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 17, 2023. This trademark is owned by Celgene Corporation. The ROJUZDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
rojuzda

General Information

Serial Number86690898
Word MarkROJUZDA
Filing DateMonday, July 13, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 17, 2023
Registration Number5034467
Registration DateTuesday, September 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, March 17, 2023CANCELLED SEC. 8 (6-YR)
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 16, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 9, 2016ASSIGNED TO LIE
Thursday, May 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 11, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 14, 2015NON-FINAL ACTION E-MAILED
Monday, December 14, 2015NON-FINAL ACTION WRITTEN
Thursday, December 10, 2015DATA MODIFICATION COMPLETED
Saturday, November 28, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 16, 2015ASSIGNED TO LIE
Tuesday, October 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 29, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION WRITTEN
Friday, September 18, 2015ASSIGNED TO EXAMINER
Monday, July 20, 2015TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, July 20, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, July 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 16, 2015NEW APPLICATION ENTERED

Related Keywords

rojuzda disease pharmaceutical preparations namely inflammation oncology fields immunology cytokine immune